Evestia Clinical Expands Global CRO Platform With ICRC-Weyer
LONDON, UNITED KINGDOM | January 27, 2026 — Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO),...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
LONDON, UNITED KINGDOM | January 27, 2026 — Evestia Clinical, a leading independent global specialist Contract Research Organization (CRO),...
